David J. Lederer
Impact in
- Pulmonary and Respiratory Medicine top 0.02%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pulmonary Hypertension Research and Treatments
- Medical Imaging and Pathology Studies
- Occupational and environmental lung diseases
- Transplantation top 0.5%
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 97
- Chronic Obstructive Pulmonary Disease (COPD) Research 29
- Pulmonary Hypertension Research and Treatments 25
- Medical Imaging and Pathology Studies 16
- Surgery 95
- Transplantation: Methods and Outcomes 90
- Organ Transplantation Techniques and Outcomes 24
- Co-authors
- Fernando J. Martínez (7 shared papers)Steven M. Kawut (65 shared papers)Steven D. Nathan (11 shared papers)LISA H. LANCASTER (11 shared papers)Selim M. Arcasoy (48 shared papers)Marilyn K. Glassberg (10 shared papers)Jeffrey J. Swigris (10 shared papers)Ian Glaspole (9 shared papers)
- Journals
- American Journal of Respiratory and Critical Care Medicine (39 papers)The Journal of Heart and Lung Transplantation (35 papers)CHEST Journal (26 papers)Annals of the American Thoracic Society (25 papers)American Journal of Transplantation (20 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
David J. Lederer
285 papers receiving 25.0k citations
David J. Lederer's Hit Papers
Peers
Comparison fields: 5 of 177
- Pulmonary and Respiratory Medicine 16.0k
- Transplantation 739
- Physiology 3.7k
- Surgery 4.6k
- Geriatrics and Gerontology 222
Countries citing papers authored by David J. Lederer
This map shows the geographic impact of David J. Lederer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Lederer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Lederer more than expected).
Fields of papers citing papers by David J. Lederer
This network shows the impact of papers produced by David J. Lederer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Lederer. The network helps show where David J. Lederer may publish in the future.
Co-authors
The 25 scholars most cited alongside David J. Lederer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 291 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2014 | 3085 |
| 2 | Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline Hit paper breakdown → | 2018 | 2999 |
| 3 | Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2018 | 1513 |
| 4 | Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report Hit paper breakdown → | 2016 | 1088 |
| 5 | A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation Hit paper breakdown → | 2014 | 1006 |
| 6 | Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline Hit paper breakdown → | 2020 | 640 |
| 7 | Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals Hit paper breakdown → | 2018 | 551 |
| 8 | Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation Hit paper breakdown → | 2013 | 546 |
| 9 | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 Hit paper breakdown → | 2021 | 501 |
| 10 | Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial Hit paper breakdown → | 2019 | 485 |
| 11 | Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan Hit paper breakdown → | 2013 | 447 |
| 12 | Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials Hit paper breakdown → | 2015 | 372 |
| 13 | Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading Hit paper breakdown → | 2011 | 369 |
| 14 | 2006 | 338 | |
| 15 | Association Between Long-term Exposure to Ambient Air Pollution and Change in Quantitatively Assessed Emphysema and Lung Function Hit paper breakdown → | 2019 | 300 |
| 16 | 2016 | 271 | |
| 17 | 2011 | 250 | |
| 18 | 2019 | 239 | |
| 19 | 2009 | 234 | |
| 20 | 2016 | 230 |
About David J. Lederer
David J. Lederer is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Physiology, Transplantation and Immunology, having authored 291 papers that have together received 25.6k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (97 papers), Transplantation: Methods and Outcomes (90 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers), Pulmonary Hypertension Research and Treatments (25 papers), Asthma and respiratory diseases (24 papers), Organ Transplantation Techniques and Outcomes (24 papers), Medical Imaging and Pathology Studies (16 papers) and Renal Transplantation Outcomes and Treatments (15 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (16.0k citations), Transplantation (739 citations), Physiology (3.7k citations), Surgery (4.6k citations) and Geriatrics and Gerontology (222 citations). David J. Lederer has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Fernando J. Martínez, Steven M. Kawut, Steven D. Nathan, LISA H. LANCASTER, Selim M. Arcasoy, Marilyn K. Glassberg, Jeffrey J. Swigris, Ian Glaspole, Paul W. Noble and Williamson Z. Bradford. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, The Journal of Heart and Lung Transplantation, CHEST Journal, Annals of the American Thoracic Society and American Journal of Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.